Molecular targeting of acid ceramidase: Implications to cancer therapy

Youssef H. Zeidan, Russell W. Jenkins, John B. Korman, Xiang Liu, Lina M. Obeid, James S. Norris, Yusuf A. Hannun

Research output: Contribution to journalReview article

60 Scopus citations

Abstract

Increasingly recognized as bioactive molecules, sphingolipids have been studied in a variety of disease models. The impact of sphingolipids on cancer research facilitated the entry of sphingolipid analogues and enzyme modulators into clinical trials. Owing to its ability to regulate two bioactive sphingolipids, ceramide and sphingosine-1-phosphate, acid ceramidase (AC) emerges as an attractive target for drug development within the sphingolipid metabolic pathway. Indeed, there is extensive evidence supporting a pivotal role for AC in lipid metabolism and cancer biology. In this article, we review the current knowledge of the biochemical properties of AC, its relevance to tumor promotion, and its molecular targeting approaches.

Original languageEnglish (US)
Pages (from-to)653-661
Number of pages9
JournalCurrent drug targets
Volume9
Issue number8
DOIs
StatePublished - 2008

Keywords

  • Cancer therapy
  • Ceramidase
  • Ceramide
  • Sphingolipids
  • Sphingosine

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Molecular targeting of acid ceramidase: Implications to cancer therapy'. Together they form a unique fingerprint.

  • Cite this

    Zeidan, Y. H., Jenkins, R. W., Korman, J. B., Liu, X., Obeid, L. M., Norris, J. S., & Hannun, Y. A. (2008). Molecular targeting of acid ceramidase: Implications to cancer therapy. Current drug targets, 9(8), 653-661. https://doi.org/10.2174/138945008785132358